SEC Info - Aronson Jeffrey, et al. - ‘3’ for 11/17/10 re: K-V Pharmaceutical Co.

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

U.S. Healthcare I, L.L.C.

(Last)

(First)

(Middle)

375 PARK AVENUE, 12TH FLOOR

(Street)

NEW YORK

10152

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/17/10

3. Issuer Name and Ticker or Trading Symbol
KV PHARMACEUTICAL CO /DE/ [ KV.A ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Warrant	11/17/10	11/17/15	Class A Common Stock	9,900,000	1.62	I	See footnote ⁽¹⁾
Warrant	11/30/10	11/17/15	Class A Common Stock	2,687,511	1.62	I	See footnote ⁽¹⁾

1. Name and Address of Reporting Person^*

U.S. Healthcare I, L.L.C.

(Last)

(First)

(Middle)

375 PARK AVENUE, 12TH FLOOR

(Street)

NEW YORK

10152

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Centerbridge Partners Holdings, LLC

(Last)

(First)

(Middle)

375 PARK AVENUE, 12TH FLOOR

(Street)

NEW YORK

10152

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Centerbridge Credit Advisors, L.L.C.

(Last)

(First)

(Middle)

375 PARK AVENUE, 12TH FLOOR

(Street)

NEW YORK

10152

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Centerbridge Special Credit Advisors, L.L.C.

(Last)

(First)

(Middle)

375 PARK AVENUE, 12TH FLOOR

(Street)

NEW YORK

10152

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

U.S. Healthcare II, L.L.C.

(Last)

(First)

(Middle)

375 PARK AVENUE, 12TH FLOOR

(Street)

NEW YORK

10152

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Aronson Jeffrey

(Last)

(First)

(Middle)

375 PARK AVENUE, 12TH FLOOR

(Street)

NEW YORK

10152

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Gallogly Mark T

(Last)

(First)

(Middle)

375 PARK AVENUE, 12TH FLOOR

(Street)

NEW YORK

10152

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Centerbridge Partners, L.P.

(Last)

(First)

(Middle)

375 PARK AVENUE, 12TH FLOOR

(Street)

NEW YORK

10152

(City)

(State)

(Zip)

Explanation of Responses:

(1) The securities reported herein are held directly by each of U.S. Healthcare I, L.L.C. ("USH I") and U.S. Healthcare II, L.L.C. ("USH II"). Centerbridge Partners Holdings, LLC ("CPH") is the general partner of Centerbridge Partners, L.P. ("CP"), which is the managing member of each of Centerbridge Credit Advisors, L.L.C. ("CCA") and Centerbridge Special Credit Advisors, L.L.C. ("CSCA"). CCA and CSCA are the investment managers of each of USH I and USH II, respectively, with respect to which each has voting and dispositive authority over the securities reported herein. Messrs. Aronson and Gallogly are the managing members of CPH. Therefore, CPH, CP, CCA , CSCA and Messrs. Aronson and Gallogly may be deemed to be the beneficial owners of the securities reported herein. Each of CPH, CP, CCA , CSCA and Messrs. Aronson and Gallogly disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein.

Remarks:

	CENTERBRIDGE PARTNERS, L.P., By: Centerbridge Partners Holdings, LLC, its general partner, /s/ Jeffrey H. Aronson, Managing Member	11/29/10
	CENTERBRIDGE PARTNERS HOLDINGS, LLC, /s/ Jeffrey H. Aronson, Managing Member	11/29/10
	CENTERBRIDGE CREDIT ADVISORS, L.L.C., By: Centerbridge Partners, L.P., its managing member,By: Centerbridge Partners Holdings, LLC, its general partner, /s/ Jeffrey H. Aronson, Managing Member	11/29/10
	CENTERBRIDGE SPECIAL CREDIT ADVISORS, L.L.C., By: Centerbridge Partners, L.P., its managing member, By: Centerbridge Partners Holdings, LLC, its general partner, /s/ Jeffrey H. Aronson, Managing Member	11/29/10
	U.S. HEALTHCARE I, L.L.C., By: Centerbridge Credit Advisors, L.L.C., its manager, By: Centerbridge Partners, L.P., its managing member, By: Centerbridge Partners Holdings, LLC, its general partner, /s/ Jeffrey H. Aronson, Managing Member	11/29/10
	U.S. HEALTHCARE II, L.L.C., By: Centerbridge Special Credit Advisors, L.L.C., its manager, By: Centerbridge Partners, L.P., its managing member, By: Centerbridge Partners Holdings, LLC, its general partner, /s/ Jeffrey H. Aronson, Managing Member	11/29/10
	JEFFREY H. ARONSON, /s/ Jeffrey H. Aronson	11/29/10
	MARK T. GALLOGLY, /s/ Mark T. Gallogly	11/29/10
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Aronson Jeffrey, et al. – ‘3’ for 11/17/10 re: K-V Pharmaceutical Co.

On: Monday, 11/29/10, at 5:27pm ET · For: 11/17/10 · As: 10% Owner · Accession #: 1140361-10-47367 · File #: 1-09601

Previous ‘3’: ‘3’ on 5/12/08 for 4/30/08 · Next: ‘3’ on / for 1/27/11 · Latest: ‘3/A’ on 1/26/22 for 1/12/22

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34
Filing Table of Contents

‘3’ — Initial Statement of Beneficial Ownership of Securities by an Insider — doc1.xml/2.3

This ‘3’ Document is an XML Data File that may be rendered in various formats:

Aronson Jeffrey, et al. – ‘3’ for 11/17/10 re: K-V Pharmaceutical Co.

On: Monday, 11/29/10, at 5:27pm ET · For: 11/17/10 · As: 10% Owner · Accession #: 1140361-10-47367 · File #: 1-09601

Previous ‘3’: ‘3’ on 5/12/08 for 4/30/08 · Next: ‘3’ on / for 1/27/11 · Latest: ‘3/A’ on 1/26/22 for 1/12/22

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34Filing Table of Contents

‘3’ — Initial Statement of Beneficial Ownership of Securities by an Insider — doc1.xml/2.3

This ‘3’ Document is an XML Data File that may be rendered in various formats:

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34
Filing Table of Contents